TCT-204 Optimal duration of dual antiplatelet therapy (DAPT) after second generation drug-eluting stent (DES) implantation in elderly patients: the SECURITY-ELDERLY substudy

Autor:	Neus Salvatella, Alberto Menozzi, Gennaro Giustino, Roberto Garbo, Patrizia Presbitero, Alaide Chieffo, Luigi Steffanon, Edoardo Pucci, Monica Masotti-Centol, A. Frasheri, Luca A. Ferri, Juan Francisco Oteo Dominguez, Antonio Colombo, Gennaro Sardella, Josepa Mauri, Giuseppe Tarantini
Rok vydání:	2016
Předmět:	medicine.medical_specialty education.field_of_study business.industry medicine.medical_treatment Population Percutaneous coronary intervention Surgery Drug-eluting stent Internal medicine Conventional PCI medicine Cardiology Cardiology and Cardiovascular Medicine business education
Zdroj:	Journal of the American College of Cardiology. 68:B83
ISSN:	0735-1097
DOI:	10.1016/j.jacc.2016.09.255
Popis:	The randomized SECURITY trial ([NCT00944333][1]) showed non-inferiority of 6 vs 12 month DAPT after DES implantation in a low-risk population treated with percutaneous coronary intervention (PCI). We aim to assess the outcome of elderly (≥75 year old) in comparison to younger patients (
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::ebf96ac732bad88349074ea799de309b https://doi.org/10.1016/j.jacc.2016.09.255 Zobrazit plný text záznamu